S282: A RANDOMIZED CONTROLLED CLINICAL TRIAL DEMONSTRATES THAT PLASMA FROM CONVALESCENT AND VACCINATED DONORS IMPROVES OUTCOME OF COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISEASE, CANCER OR IMMUNOSUPPRESSION

• C. Müller-Tidow,
• M. Janssen,
• U. Schäkel,
• J. Gall,
• A. Leo,
• P. Stelmach,
• J. Krisam,
• L. Baumann,
• J. Stermann,
• U. Merle,
• M. Zeier,
• M. A. Weigand,
• L. Bullinger,
• J.-F. Schrezenmeier,
• M. Bornhäuser,
• N. Alakel,
• O. Witzke,
• T. Wolf,
• M. J. Vehreschild,
• S. Schmiedel,
• M. M. Addo,
• F. Herth,
• M Kreutner,
• P.-R. Tepasse,
• B. Hertenstein,
• M. Hänel,
• A. Morgner,
• M. Kiehl,
• O. Hopfer,
• M.-A. Wattad,
• C. C. Schimanski,
• C Celik,
• T. Pohle,
• M. Ruhe,
• W. V. Kern,
• A Schmitt,
• M. Schmitt,
• P. Dreger,
• H.-M. Lorenz,
• M. Souto-Carneiro,
• N. Halama,
• S. Meuer,
• H.-G. Kräusslich,
• B. Müller,
• R. Bartenschlager,
• J. Klemmer,
• K. Kriegsmann,
• R. F. Schlenk,
• C. M. Denkinger

Affiliations

C. Müller-Tidow

1 Department of Internal Medicine V, Heidelberg University Hospital

M. Janssen

1 Department of Internal Medicine V, Heidelberg University Hospital

U. Schäkel

1 Department of Internal Medicine V, Heidelberg University Hospital

J. Gall

2 NCT-Trial Center, National Center of Tumor Diseases, Heidelberg University Hospital

A. Leo

4 Institute for Clinical Transfusion Medicine and Cell Therapy Heidelberg

P. Stelmach

1 Department of Internal Medicine V, Heidelberg University Hospital

J. Krisam

5 Institute for Medical Biometry and Informatics, Ruprecht-Karls University Heidelberg

L. Baumann

5 Institute for Medical Biometry and Informatics, Ruprecht-Karls University Heidelberg

J. Stermann

5 Institute for Medical Biometry and Informatics, Ruprecht-Karls University Heidelberg

U. Merle

6 Department of Internal Medicine IV, Heidelberg University Hospital

M. Zeier

7 Department of Nephrology, University of Heidelberg, Heidelberg

M. A. Weigand

8 Department of Anaesthesiology, Heidelberg University Hospital, Heidelberg, Heidelberg

L. Bullinger

9 Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Campus Virchow Clinic, Berlin

J.-F. Schrezenmeier

9 Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Campus Virchow Clinic, Berlin

M. Bornhäuser

10 Department of Internal Medicine I, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Dresden

N. Alakel

10 Department of Internal Medicine I, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Dresden

O. Witzke

11 Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen

T. Wolf

12 Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main

M. J. Vehreschild

12 Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main

S. Schmiedel

13 I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg

M. M. Addo

13 I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg

F. Herth

14 Pneumology and Critical Care Medicine, Thoraxklinik, University of Heidelberg

M Kreutner

15 Center for Interstitial and Rare Lung Diseases, Thoraxklinik, University of Heidelberg, German Center for Lung Research (DZL), Heidelberg

P.-R. Tepasse

16 Department of Medicine B, Gastroenterology and Hepatology, University Hospital Münster, Münster

B. Hertenstein

17 Medical Department I, Klinikum Bremen-Mitte, Bremen

M. Hänel

18 Department of Internal Medicine III, Klinikum Chemnitz gGmbH, Chemnitz

A. Morgner

18 Department of Internal Medicine III, Klinikum Chemnitz gGmbH, Chemnitz

M. Kiehl

19 Department I of Internal Medicine, Frankfurt (Oder) General Hospital, Frankfurt (Oder)

O. Hopfer

19 Department I of Internal Medicine, Frankfurt (Oder) General Hospital, Frankfurt (Oder)

M.-A. Wattad

20 Department of Hematology, Oncology, Palliative Care and Stem Cell Transplantation, Klinikum Hochsauerland GmbH, Meschede

C. C. Schimanski

21 Department of Internal Medicine II, Klinikum Darmstadt GmbH, Darmstadt

C Celik

21 Department of Internal Medicine II, Klinikum Darmstadt GmbH, Darmstadt

T. Pohle

22 Department of Internal Medicine I, Klinikum Herford, Herford

M. Ruhe

22 Department of Internal Medicine I, Klinikum Herford, Herford

W. V. Kern

23 Department of Medicine II, Division of Infectious Diseases and Travel Medicine, University Medical Centre Freiburg, Freiburg

A Schmitt

1 Department of Internal Medicine V, Heidelberg University Hospital

M. Schmitt

1 Department of Internal Medicine V, Heidelberg University Hospital

P. Dreger

1 Department of Internal Medicine V, Heidelberg University Hospital

H.-M. Lorenz

1 Department of Internal Medicine V, Heidelberg University Hospital

M. Souto-Carneiro

1 Department of Internal Medicine V, Heidelberg University Hospital

N. Halama

24 Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital

S. Meuer

4 Institute for Clinical Transfusion Medicine and Cell Therapy Heidelberg

H.-G. Kräusslich

25 Department of Infectious Diseases, Virology, Heidelberg University Hospital

B. Müller

25 Department of Infectious Diseases, Virology, Heidelberg University Hospital

R. Bartenschlager

26 Department of Infectious Diseases, Molecular Virology, Heidelberg University Hospital

J. Klemmer

1 Department of Internal Medicine V, Heidelberg University Hospital

K. Kriegsmann

1 Department of Internal Medicine V, Heidelberg University Hospital

R. F. Schlenk

1 Department of Internal Medicine V, Heidelberg University Hospital

C. M. Denkinger

27 Division of Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany